Structure.jpg (Evoclin 1)
Clindamycin Phosphate Aerosol, Foam
Product Images NDC 68462-605
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Clindamycin Phosphate (NDC 68462-605). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Glenmark (Glenmark 01)
Glenmark (Glenmark Logo 1)
Glenmark (Glenmark)
Image-01.jpg (Image 01)
Carton-label.jpg (Image 02)
Description: Clindamycin Phosphate Foam, 1%, is a topical medication used for treating certain skin conditions. It contains clindamycin phosphate, which is equivalent to 10 mg of clindamycin per gram. The foam is applied to the affected area and is formulated with a hydroethanolic vehicle. It is prescribed by a physician and should be used as directed. The medication is flammable, so precautions should be taken to avoid fire, flame, or smoking during and after application. It should be kept out of reach of children and should not come in contact with the eyes. The foam is pressurized and should not be punctured or incinerated. It should be stored at a temperature between 20°C to 25°C (68°F to 77°F). The medication is manufactured by Glenmark Pharmaceuticals Inc. and is distributed in the USA. For more information, contact Glenmark Pharmaceuticals Inc.*
Image-02.jpg (Image 03)
Image-03.jpg (Image 04)
Image-04.jpg (Image 05)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
